ACCESSIBILITY
  Text size:
Small | Medium | Large
Contrast:
Normal | High
 
 
OLDER PEOPLE LEARNING DISABILITIES MENTAL HEALTH

Schizophrenia drug trial questioned

27 August 2008

The US Food and Drug Administration (FDA) has requested more data on a schizophrenia treatment developed by Johnson & Johnson (J&J).

J&J has been sent a "complete response" letter from the FDA, but the firm has not been ordered to carry out a second trial for the new drug.

The company said the letter outlined further questions that needed to be addressed.

During J&J's clinical trial of the intramuscular drug paliperidone palmitate, which is taken once a month, psychiatrist David Hough found the anti-psychotic reduced the likelihood of a relapse in patients suffering from schizophrenia to between ten and 15 per cent.

J&J halted the drug trial early because of the clear benefits of the drug, which was tested against a placebo.

Paliperidone palmitate uses patented NanoCrystal technology developed by Elan Pharma International.

If J&J comply with the FDA's requests paliperidone palmitate could provide a new treatment for patients suffering from schizophrenia in the near future, according to webmd.com.

ADNFCR-695-ID-18751412-ADNFCR© Adfero Ltd

© 2008 Adfero Ltd. All rights reserved. Any views and opinions expressed in news articles are not those of Craegmoor Limited and its associated companies. News supplied by Adfero DirectNews.

Bookmark with:

What are these?

Add to del.icio.us Delicious Add to Digg! Digg Add to reddit reddit Add to Facebook Facebook Add to StumbleUpon StumbleUpon

Related stories

02/07/2009 Four pints a week increases hospital risk, research finds
New research has found that drinking four pints a week is enough to increase the risk of a person needing hospital and mental health treatment in their lifetime.

01/07/2009 Complicated pregnancy could increase risk of autism, suggests study
Complicated pregnancy could increase risk of autism, suggests study

01/07/2009 Preferred bidder announced for £100m mental health project.
An NHS service has said who it wants to take control of its £100 million mental health project.

30/06/2009 Bruno thanks nurses who helped him with mental health issues
Former world champion boxer and English darling Frank Bruno has been to thank the nurses who helped him recover from his much publicised mental health problems.

29/06/2009 CBT 'is an ineffective schizophrenia treatment'
Cognitive behavioural therapy (CBT) is an ineffective treatment for the mental health condition schizophrenia, new research claims.

0800 0232 595 Referral Hotline
SEARCH THE SITE
   
 
HOMES AND HOSPITAL DIRECTORY QUICK SEARCH
  
  
 

Advanced search
 
 
Craegmoor life Call Craegmoor Featured articles Download our brochures